S&P 500   4,589.55 (-1.41%)
DOW   34,609.04 (-1.50%)
QQQ   393.50 (-1.55%)
AAPL   164.02 (+2.36%)
MSFT   330.98 (-1.68%)
FB   326.94 (-3.28%)
GOOGL   2,848.77 (-2.12%)
AMZN   3,505.70 (-1.57%)
TSLA   1,129.81 (-0.63%)
NVDA   321.52 (-3.67%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.70 (-1.67%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,589.55 (-1.41%)
DOW   34,609.04 (-1.50%)
QQQ   393.50 (-1.55%)
AAPL   164.02 (+2.36%)
MSFT   330.98 (-1.68%)
FB   326.94 (-3.28%)
GOOGL   2,848.77 (-2.12%)
AMZN   3,505.70 (-1.57%)
TSLA   1,129.81 (-0.63%)
NVDA   321.52 (-3.67%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.70 (-1.67%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,589.55 (-1.41%)
DOW   34,609.04 (-1.50%)
QQQ   393.50 (-1.55%)
AAPL   164.02 (+2.36%)
MSFT   330.98 (-1.68%)
FB   326.94 (-3.28%)
GOOGL   2,848.77 (-2.12%)
AMZN   3,505.70 (-1.57%)
TSLA   1,129.81 (-0.63%)
NVDA   321.52 (-3.67%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.70 (-1.67%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,589.55 (-1.41%)
DOW   34,609.04 (-1.50%)
QQQ   393.50 (-1.55%)
AAPL   164.02 (+2.36%)
MSFT   330.98 (-1.68%)
FB   326.94 (-3.28%)
GOOGL   2,848.77 (-2.12%)
AMZN   3,505.70 (-1.57%)
TSLA   1,129.81 (-0.63%)
NVDA   321.52 (-3.67%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.70 (-1.67%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
NASDAQ:MYMD

MyMD Pharmaceuticals News Headlines

$7.55
-0.04 (-0.53%)
(As of 11/30/2021 01:17 PM ET)
Add
Compare
Today's Range
$7.39
$7.86
50-Day Range
$5.95
$9.69
52-Week Range
$3.30
$10.48
Volume
3,746 shs
Average Volume
341,232 shs
Market Capitalization
$284.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.42

Media Mentions By Week



MyMD Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MYMD
News Sentiment

1.14

0.27

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MYMD Articles
This Week

6

1

MYMD Articles
Average Week

Get MyMD Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MYMD and its competitors with MarketBeat's FREE daily newsletter.

MyMD Pharmaceuticals (NASDAQ:MYMD) News Headlines Today

SourceHeadline
MarketBeat logoJoshua Silverman Purchases 5,000 Shares of MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) Stock
americanbankingnews.com - November 29 at 2:08 PM
MarketBeat logoMyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) Director Joshua Silverman Acquires 10,000 Shares
americanbankingnews.com - November 29 at 2:08 PM
MarketBeat logoPaul Rivard Purchases 15,000 Shares of MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) Stock
americanbankingnews.com - November 24 at 2:10 PM
finance.yahoo.com logoMyMD Pharmaceuticals Announces Issuance of U.S. Patent Covering Lead Drug Candidate MYMD-1 in a Method of Extending Lifespan
finance.yahoo.com - November 23 at 9:39 AM
finance.yahoo.com logoMyMD Pharmaceuticals Investment Company Oravax Medical and Genomma Lab Announce Joint Venture to Develop and Commercialize Oral COVID-19 Vaccine in Mexico and Drive Business Development in Latin America
finance.yahoo.com - November 18 at 9:19 AM
finance.yahoo.com logoMyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
finance.yahoo.com - November 16 at 11:16 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating MyMD Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
finance.yahoo.com - November 15 at 10:15 AM
MarketBeat logoMyMD Pharmaceuticals (NASDAQ:MYMD) Trading 0.3% Higher
americanbankingnews.com - November 10 at 2:20 AM
finance.yahoo.com logoMyMD Pharmaceuticals President Chris Chapman, M.D. Named Medical Honoree of the Year by the Arthritis Foundation
finance.yahoo.com - October 26 at 11:52 AM
finance.yahoo.com logoMyMD Pharmaceuticals to Discuss its Novel Therapies for Aging and Related Diseases at the Dawson James Securities 6th Annual Small Cap Growth Conference on October 21
finance.yahoo.com - October 19 at 12:40 PM
finance.yahoo.com logoMyMD Pharmaceuticals Announces New Data Demonstrating 8,000 Times Higher Potency of Novel Synthetic Supera-CBD over Plant-Derived CBD
finance.yahoo.com - September 22 at 3:29 PM
finance.yahoo.com logoMyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan
finance.yahoo.com - September 13 at 5:50 PM
finance.yahoo.com logoMyMD Pharmaceuticals to Present its Novel Therapeutic Platforms for Extending Healthy Lifespan at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15
finance.yahoo.com - September 9 at 4:10 PM
finance.yahoo.com logoMyMD Pharmaceuticals Announces Issuance of U.S. Patent for Use of Lead Candidate MYMD-1 for Treating Fibrosis and Asthma
finance.yahoo.com - August 24 at 2:05 PM
nasdaq.com logoHere's Why We're Not Too Worried About MyMD Pharmaceuticals' (NASDAQ:MYMD) Cash Burn Situation
nasdaq.com - August 23 at 3:39 PM
finance.yahoo.com logoWe Think MyMD Pharmaceuticals (NASDAQ:MYMD) Can Afford To Drive Business Growth
finance.yahoo.com - August 23 at 9:23 AM
finance.yahoo.com logoMyMD Pharmaceuticals Announces Issuance of U.S. Patent for Synthetic Cannabinoid Compounds for Treating Neuroinflammatory and Neurodegenerative Diseases
finance.yahoo.com - August 10 at 5:34 PM
nasdaq.com logoMyMD Pharma's Unit Oravax Medical Preparing To Commence Clinical Trials For Oral COVID-19 Vaccine
nasdaq.com - August 10 at 12:34 PM
finance.yahoo.com logoMyMD Pharmaceuticals Subsidiary Oravax Medical Preparing to Commence Clinical Trials for Oral COVID-19 Vaccine
finance.yahoo.com - August 10 at 12:34 PM
benzinga.com logoMyMD Pharmaceuticals' Lead Compound MYMD-1 Shown to Suppress a Major Cause of Death in COVID-19 in Human Cell Study
benzinga.com - August 7 at 9:54 PM
in.finance.yahoo.com logoSteven P. Cohen, Chief of Pain Medicine at Johns Hopkins, Joins Releviate Therapeutics as Head of Its Scientific Advisory Board
in.finance.yahoo.com - July 29 at 9:04 AM
finance.yahoo.com logoMyMD Pharmaceuticals’ Lead Compound MYMD-1 Shows Commonality in Comparative Study with FDA-Approved Anti-Inflammatory and Anti-Autoimmune Drugs Used for Arthritis, Colitis and Dermatitis
finance.yahoo.com - July 27 at 1:52 PM
finance.yahoo.com logoMyMD Pharmaceuticals Set to Join Russell Microcap® Index
finance.yahoo.com - June 7 at 1:07 PM
finance.yahoo.com logoMyMD Pharmaceuticals Appoints David Rini, Professor at the Johns Hopkins School of Medicine, to Scientific Advisory Board
finance.yahoo.com - May 17 at 1:55 PM
benzinga.com logoFrom BZ Small Cap Event: MYMD Pharmaceuticals Adam Kaplin Says Treatment With Co.'s MyMD-1 One Month Has How Mood Differences
benzinga.com - May 14 at 8:10 AM
finance.yahoo.com logoMyMD Pharmaceuticals Schedules Business Update Conference Call
finance.yahoo.com - May 12 at 1:47 PM
finance.yahoo.com logoMyMD Pharmaceuticals: Invitation to the Benzinga Global Small Cap Conference
finance.yahoo.com - May 10 at 10:18 AM
benzinga.com logoJohns Hopkins Medicine Researchers to Present Data on MyMD Pharmaceuticals' Supera-CBD at the 3rd Annual Neuroimmunology Drug Development Summit
benzinga.com - April 30 at 1:32 PM
finance.yahoo.com logoJohns Hopkins Medicine Researchers to Present Data on MyMD Pharmaceuticals’ Supera-CBD at the 3rd Annual Neuroimmunology Drug Development Summit
finance.yahoo.com - April 28 at 1:00 PM
finance.yahoo.com logoMyMD Pharmaceuticals Announces Issuance of Allowance from United States Patent and Trademark Office for Synthetic Cannabinoid Compounds
finance.yahoo.com - April 27 at 4:52 PM
Get MyMD Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MYMD and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.